Literature DB >> 28387325

HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.

Karl Kashofer1, Elke Winter1, Iris Halbwedl1, Andrea Thueringer1, Marisa Kreiner1, Stefan Sauer1, Sigrid Regauer1.   

Abstract

The majority of penile squamous cell carcinomas is caused by transforming human papilloma virus (HPV) infection. The etiology of HPV-negative cancers is unclear, but TP53 mutations have been implicated. Archival tissues of 108 invasive squamous cell carcinoma from a single pathology institution in a low-incidence area were analyzed for HPV-DNA and p16ink4a overexpression and for TP53 mutations by ion torrent next-generation sequencing. Library preparation failed in 32/108 squamous cell carcinomas. Institutional review board approval was obtained. Thirty of 76 squamous cell carcinomas (43%; average 63 years) were HPV-negative with 8/33 squamous cell carcinomas being TP53 wild-type (24%; average 63 years). Twenty-five of 33 squamous cell carcinomas (76%; average 65 years) showed 32 different somatic TP53 mutations (23 missense mutations in exons 5-8, 6 nonsense, 1 frameshift and 2 splice-site mutations). Several hotspot mutations were detected multiple times (R175H, R248, R282, and R273). Eighteen of 19 squamous cell carcinomas with TP53 expression in immunohistochemistry had TP53 mutations. Fifty percent of TP53-negative squamous cell carcinomas showed mostly truncating loss-of-function TP53 mutations. Patients without mutations had longer survival (5 years: 86% vs 61%; 10 years: 60% vs 22%), but valid clinically relevant conclusions cannot be drawn due to different tumor stages and heterogeneous treatment of the cases presented in this study. Somatic TP53 mutations are a common feature in HPV-negative penile squamous cell carcinomas and offer an explanation for HPV-independent penile carcinogenesis. About half of HPV-negative penile cancers are driven by oncogenic activation of TP53, while a quarter is induced by loss of TP53 tumor suppressor function. Detection of TP53 mutations should be carried out by sequencing, as immunohistochemical TP53 staining could not identify all squamous cell carcinomas with TP53 mutations.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28387325     DOI: 10.1038/modpathol.2017.26

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  32 in total

1.  Role of TP53 mutations in vulvar carcinomas.

Authors:  Matthias Choschzick; Widianto Hantaredja; Pierre Tennstedt; Frederike Gieseking; Linn Wölber; Ronald Simon
Journal:  Int J Gynecol Pathol       Date:  2011-09       Impact factor: 2.762

Review 2.  Mutant p53: one name, many proteins.

Authors:  William A Freed-Pastor; Carol Prives
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

Review 3.  Human papillomavirus detection in head and neck squamous cell carcinomas.

Authors:  Anthony N Snow; Jennifer Laudadio
Journal:  Adv Anat Pathol       Date:  2010-11       Impact factor: 3.875

4.  Differentiated precursor lesions and low-grade variants of squamous cell carcinomas are frequent findings in foreskins of patients from a region of high penile cancer incidence.

Authors:  Judith Oertell; Carmelo Caballero; Manuelita Iglesias; Alcides Chaux; Luís Amat; Enrique Ayala; Ingrid Rodríguez; Elsa F Velázquez; José E Barreto; Gustavo Ayala; Antonio L Cubilla
Journal:  Histopathology       Date:  2011-05       Impact factor: 5.087

5.  Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells.

Authors:  Miriam Reuschenbach; Mirjam Seiz; Christina von Knebel Doeberitz; Svetlana Vinokurova; Alexander Duwe; Ruediger Ridder; Heike Sartor; Friedrich Kommoss; Dietmar Schmidt; Magnus von Knebel Doeberitz
Journal:  Int J Cancer       Date:  2011-06-10       Impact factor: 7.396

6.  Targeting p53 for Novel Anticancer Therapy.

Authors:  Zhen Wang; Yi Sun
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

Review 7.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

8.  Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men.

Authors:  Naoki Yanagawa; Mitsumasa Osakabe; Masahiro Hayashi; Gen Tamura; Teiichi Motoyama
Journal:  Pathol Int       Date:  2008-08       Impact factor: 2.534

9.  Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression.

Authors:  B Yang; W R Hart
Journal:  Am J Surg Pathol       Date:  2000-03       Impact factor: 6.394

10.  Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma.

Authors:  Alvaro P Pinto; Alexander Miron; Yosuf Yassin; Nicolas Monte; Terri Y C Woo; Karishma K Mehra; Fabiola Medeiros; Christopher P Crum
Journal:  Mod Pathol       Date:  2010-01-08       Impact factor: 7.842

View more
  6 in total

Review 1.  [Pathology and histopathological evaluation of penile cancer].

Authors:  A Erbersdobler
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

2.  HPV-negative Penile Intraepithelial Neoplasia (PeIN) With Basaloid Features.

Authors:  José Guerrero; Isabel Trias; Luis Veloza; Marta Del Pino; Adriana Garcia; Lorena Marimon; Sherley Diaz-Mercedes; Maria T Rodrigo-Calvo; Silvia Alós; Tarek Ajami; Rafael Parra-Medina; Antonio Martinez; Oscar Reig; Maria J Ribal; Juan M Corral-Molina; Jaume Ordi; Inmaculada Ribera-Cortada; Natalia Rakislova
Journal:  Am J Surg Pathol       Date:  2022-03-17       Impact factor: 6.298

Review 3.  Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.

Authors:  Juan Chipollini; Sharon Chaing; Mounsif Azizi; Laura C Kidd; Patricia Kim; Philippe E Spiess
Journal:  Int J Mol Sci       Date:  2017-08-16       Impact factor: 5.923

4.  P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study.

Authors:  Robert Stoehr; Rebecca Weisser; Olaf Wendler; Johannes Giedl; Khalid Daifalla; Nadine T Gaisa; Georg Richter; Valentina Campean; Maximilian Burger; Bernd Wullich; Arndt Hartmann
Journal:  J Cancer       Date:  2018-10-20       Impact factor: 4.207

5.  Amorphous silica nanoparticles induce tumorigenesis via regulating ATP5H/SOD1-related oxidative stress, oxidative phosphorylation and EIF4G2/PABPC1-associated translational initiation.

Authors:  Dongli Xie; Yang Zhou; Xiaogang Luo
Journal:  PeerJ       Date:  2019-03-04       Impact factor: 2.984

6.  FCGR2A Could Function as a Prognostic Marker and Correlate with Immune Infiltration in Head and Neck Squamous Cell Carcinoma.

Authors:  Yongmei Dai; Wenhan Chen; Junpeng Huang; Tongjian Cui
Journal:  Biomed Res Int       Date:  2021-07-05       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.